Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FG3XZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,400
Award facts
- Contract value 100% obligated
- $5,399.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for RINVOQ ER 15 mg tablets (30-count units) with a ceiling value of $5,399.73. This is a firm fixed price delivery order with no set-aside designation, executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of June 3, 2025.
This delivery order represents a routine pharmaceutical procurement through AmerisourceBergen's comprehensive global pharmaceutical support vehicle, which enables the company to supply medications and medical supplies to military healthcare programs worldwide. RINVOQ (upadacitinib) is a prescription medication used in the treatment of rheumatoid arthritis and other inflammatory conditions, reflecting the Defense Health Agency's ongoing need for specialty medications to support military personnel and veteran healthcare. AmerisourceBergen's role as a major pharmaceutical distributor provides the federal government with critical access to brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains through competitive contract mechanisms.
Quick answers
Who was awarded contract SPE2DB25FG3XZ?
SPE2DB25FG3XZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FG3XZ worth?
The government has obligated $5,400 on SPE2DB25FG3XZ.
Is contract SPE2DB25FG3XZ an order under another contract?
Yes. SPE2DB25FG3XZ is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FG3XZ competed?
The extent of competition for SPE2DB25FG3XZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award